February 2020

Employers Support Bipartisan Bill to Increase Drug Price Transparency and Reduce Gaming by Middlemen

2020-02-24T13:56:49-05:00February 24th, 2020|EmployersRx, Policy Statement|

EmployersRx endorses H.R. 5304 as part of ongoing initiative to lower drug prices through increased competition, value, and transparency in the market WASHINGTON, D.C. – Employers’ Prescription for Affordable Drugs (EmployersRx) has announced its support of H.R. 5304, the "PBM Transparency and Prescription Drug Costs Act." This bipartisan legislation will markedly lower private health insurance

Statement of Record for House Committee on Ways and Means, Subcommittee on Health

2020-02-07T10:25:02-05:00February 7th, 2020|EmployersRx, Statement of Record|

Statement of Record for House Committee on Ways and Means, Subcommittee on Health February 5, 2020 More Cures for More Patients: Overcoming Pharmaceutical Barriers Employers’ Prescription for Affordable for Drugs (EmployersRx)   Written Statement Chairman Doggett, Ranking Member Nunes, and members of the House Ways and Means Health Subcommittee, thank you for the opportunity to

No More ‘Sucker at the Table’: New Coalition to Represent Fortune 500 Firms Paying Prescription Drug Bills

2020-02-04T16:36:38-05:00February 4th, 2020|Drug Cost News, EmployersRx, News|

Tired of being "the sucker at the table," a group representing Fortune 500 companies has formed a lobby to push congressional drug-pricing policies that focus beyond Medicare. Employers' Prescription for Affordable Drugs has described its goal as "to mobilize large employers to drive down prescription drug costs by advocating for public policies based on increased competition,

Employers Shoulder Plenty of Drug Costs, but Haven’t Lobbied Much to Lower Them — Until Now

2020-02-03T12:08:36-05:00February 3rd, 2020|Drug Cost News, EmployersRx, News|

Legislation aiming to reduce drug prices has thus far focused on changes to federal programs such as Medicare. But Walmart, Pepsi, and other large companies provide employer-sponsored health insurance to more than 150 million Americans, making them the largest footers of health bills. Now, these employers and a coalition of other Fortune 500 companies also

January 2020

Coalition Advocates for Biosimilar Uptake to Help Lower Employers’ Drug Cost Burden

2020-01-21T14:05:14-05:00January 21st, 2020|Drug Cost News, EmployersRx, News|

Rising drug costs in the United States are a pressing concern not only for patients who need to receive those drugs, but also for employers. The Employers’ Prescription for Affordable Drugs (EmployersRx) is a coalition that aims to tackle this problem by working with policy makers and stakeholders to encourage and facilitate more transparency, competition,

EmployersRx on “Not So Different”: Employers Advocate for Lower Drug Costs Through Biosimilars

2020-01-15T12:00:25-05:00January 15th, 2020|Drug Cost News, EmployersRx, News|

With pharmaceutical spending at record levels, employers are looking for solutions and are hopeful that biosimilars can play a role in controlling costs. On this episode of "Not So Different," Elizabeth Mitchell and Lauren Vela (from EmployersRx founding member Pacific Business Group on Health) spoke with Allison Inserro of The Center for Biosimilars about the

Employers’ Prescription for Affordable Drugs Welcomes Silicon Valley Employers Forum as a Coalition Member

2020-01-13T14:27:25-05:00January 13th, 2020|EmployersRx, Partner News, Press Release|

SVEF Joins PBGH, ERIC and National Alliance in Calling on Congress to Alleviate the High Cost of Prescription Drugs for Employers and Families WASHINGTON, D.C. – Employers’ Prescription for Affordable Drugs (EmployersRx) welcomes the Silicon Valley Employers Forum (SVEF) as a member in their fight to reform prescription drug pricing at the federal level. EmployersRx

December 2019

Employers Applaud Advancement of the CREATES Act and Transparency Measures, View 2020 as a Transformational Year in Drug Pricing

2019-12-19T18:04:54-05:00December 19th, 2019|EmployersRx, Policy Statement|

Elements of Policy Platform—the CREATES Act and “Purple Book” Transparency—Advance Through Congress; Large Issues Remain on Table for 2020 WASHINGTON, D.C. – Employers’ Prescription for Affordable Drugs (EmployersRx) applauded Congress for including the Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act and portions of the Biologic Patent Transparency Act in an omnibus government

November 2019

Employers: House and Senate Proposals Move Us Closer to Prescription Drug Cost Relief for Patients and Employers

2019-11-05T12:31:00-05:00November 5th, 2019|EmployersRx, Policy Statement|

WASHINGTON, D.C. – Employers’ Prescription for Affordable Drugs (EmployersRx) issued this statement in conjunction with the ongoing debate of the Lower Drug Costs Now Act of 2019 (H.R. 3), the Prescription Drug Pricing Reduction Act (S. 2543), the Lower Health Care Costs Act (S. 1895), and other legislation proposed by both parties in the U.S.

October 2019